What is a stock summary page? Click here for an overview.
Business Description
Modus Therapeutics Holding AB
ISIN : SE0015987904
Compare
Compare
Traded in other countries / regions
MODTX.Sweden99Z.Germany IPO Date
2021-07-30Description
Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.8 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -35.2 | |||||
| 3-Year EPS without NRI Growth Rate | -39.3 | |||||
| 3-Year FCF Growth Rate | -27.9 | |||||
| 3-Year Book Growth Rate | 4.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.41 | |||||
| 9-Day RSI | 48.07 | |||||
| 14-Day RSI | 49.2 | |||||
| 3-1 Month Momentum % | -24.13 | |||||
| 6-1 Month Momentum % | -16.86 | |||||
| 12-1 Month Momentum % | 29.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.87 | |||||
| Quick Ratio | 4.87 | |||||
| Cash Ratio | 4.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -228.99 | |||||
| ROA % | -119.28 | |||||
| ROIC % | -294.58 | |||||
| 3-Year ROIIC % | -1464.03 | |||||
| ROCE % | -226.83 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.07 | |||||
| Price-to-Tangible-Book | 5.33 | |||||
| EV-to-EBIT | -2.28 | |||||
| EV-to-Forward-EBIT | -0.84 | |||||
| EV-to-EBITDA | -2.28 | |||||
| EV-to-Forward-EBITDA | -0.84 | |||||
| EV-to-FCF | -2.37 | |||||
| Price-to-Net-Current-Asset-Value | 5.33 | |||||
| Price-to-Net-Cash | 5.33 | |||||
| Earnings Yield (Greenblatt) % | -43.86 | |||||
| FCF Yield % | -34.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Modus Therapeutics Holding AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.04 | ||
| Beta | 0.51 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.56 | ||
| Volatility % | 78.41 | ||
| 14-Day RSI | 49.2 | ||
| 14-Day ATR (€) | 0.008855 | ||
| 20-Day SMA (€) | 0.105345 | ||
| 12-1 Month Momentum % | 29.78 | ||
| 52-Week Range (€) | 0.0734 - 0.1915 | ||
| Shares Outstanding (Mil) | 35.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Modus Therapeutics Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Modus Therapeutics Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Modus Therapeutics Holding AB Frequently Asked Questions
What is Modus Therapeutics Holding AB(FRA:99Z)'s stock price today?
The current price of FRA:99Z is €0.11. The 52 week high of FRA:99Z is €0.19 and 52 week low is €0.07.
When is next earnings date of Modus Therapeutics Holding AB(FRA:99Z)?
The next earnings date of Modus Therapeutics Holding AB(FRA:99Z) is 2025-05-14.
Does Modus Therapeutics Holding AB(FRA:99Z) pay dividends? If so, how much?
Modus Therapeutics Holding AB(FRA:99Z) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers